Is this you? Create Your Porfile
Avatar

Jeffrey T. Bien

Bristol-Myers Squibb

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Jeffrey T. Bien is active.

Explore More

Publication

Featured researches published by Jeffrey T. Bien.

Archive | 2007

Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes

Jack Z. Gougoutas; Alexandra A. Nirschl; Janak Singh; John D. Dimarco; Hildegard Lobinger; Srividya Ramakrishnan; Prashant P. Deshpande; Jeffrey T. Bien; Chiajen Lai; Chenchi Wang; Peter Riebel; John Anthony Grosso

Archive | 2007

Crystal structures of SGLT2 inhibitors and processes for preparing same

Jack Z. Gougoutas; Hildegard Lobinger; Srividya Ramakrishnan; Prashant P. Deshpande; Jeffrey T. Bien; Chiajen Lai; Chenchi Wang; Peter Riebel; John Anthony Grosso; Alexandra A. Nirschl; Janak Singh; John D. Dimarco

Organic Process Research & Development | 2009

The Process Development of Ravuconazole: An Efficient Multikilogram Scale Preparation of an Antifungal Agent(1)

Jaan A. Pesti; Chien-Kuang Chen; Lori Spangler; Albert J. DelMonte; Serge Benoit; Derek Berglund; Jeffrey T. Bien; Paul R. Brodfuehrer; Yeung Y. Chan; Elisabeth Corbett; Carrie A. Costello; Paul Demena; Robert P. Discordia; Wendel W. Doubleday; Zhinong Gao; Stephane Gingras; John Anthony Grosso; Oscar W. Haas; David Kacsur; Chiajen Lai; Simon Leung; Melanie Miller; Jale Muslehiddinoglu; Nina Nguyen; Jun Qiu; Martina Olzog; Emily A. Reiff; Dominique Thoraval; Michael J. Totleben; Dale Vanyo

Organic Process Research & Development | 2018

The First Kilogram Synthesis of Beclabuvir, an HCV NS5B Polymerase Inhibitor

Jeffrey T. Bien; Akin H. Davulcu; Albert J. DelMonte; Kenneth J. Fraunhoffer; Zhinong Gao; Chao Hang; Yi Hsiao; Wenhao Hu; Kishta Katipally; Adam Littke; Aghogho Pedro; Yuping Qiu; Maria Sandoval; Richard L. Schild; Michelle Soltani; Anthony Tedesco; Dale Vanyo; Purushotham Vemishetti; Robert Waltermire

Archive | 2013

Crystal structure of SGLT2 inhibitor and preparation method of crystal structure

Jack Z. Gougoutas; Hildegard Lobinger; Srividya Ramakrishnan; Prashant P. Deshpande; Jeffrey T. Bien; Chiajen Lai; Chenchi Wang; Peter Riebel; John Anthony Grosso; Alexandra A. Nirschl; Janak Singh; John D. Dimarco

Archive | 2010

METHOD FOR PRODUCING ANTIVIRAL AGENT [1S-(1α, 3α, 4β)]-2-AMINO-1,9-DIHYDRO-9-[4-HYDROXY-3-(HYDROXYMETHYL)-2-METHYLENECYCLOPENTYL]-6H-PURIN-6-ONE

Banerjee Amit; Jeffrey T. Bien; Yeung Y. Chan; Chung-Pin H. Chen; J Kucera David; Jeffrey M. Evans; Dhileepkumar Krishnamurty; David R. Kronenthal; Charles Lewis; Jing Liang; Ramesh N. Patel; Sunil S. Patel; Yadagiri Pendri; Richard Polniaszek; Gerald L. Powers; Siva Josyula Prasad; Sushil K. Rijhwani; Zhongping Shi; Ambarish K. Singh; Milan Stojanovic; John K. Thottathil; Purushotham Vemishetti; Xiao Feng Wang; Maotang X. Zhou; アミット・バナージー; アンバリッシュ・ケイ・シン; ジェフリー・エム・エバンズ; ジェフリー・ティ・ビーン; ジェラルド・エル・パワーズ; シバ・ジョシュラ・プラサド

Archive | 2007

Pharmaceutical composition comprising crystalline (2s,3r,4s,5s,6r)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3,4,5-triol (s)-propylene glycol solvate

Jack Z. Gougoutas; Alexandra A. Nirschl; Janak Singh; John D. Dimarco; Hildegard Lobinger; Srividya Ramakrishnan; Prashant P. Deshpande; Jeffrey T. Bien; Chiajen Lai; Chenchi Wang; Peter Riebel; John Anthony Grosso

Archive | 2007

Kristalline Solvate und Komplexe aus (1S)-1,5-Anhydro-1-C-(3-((Phenyl) Methyl) Phenyl)-D-Glucitol-Derivaten mit Aminosäuren als SGLT2-Inhibitoren zur Behandlung von Diabetes

Jack Z. Gougoutas; Alexandra A. Nirschl; Janak Singh; John D. Dimarco; Hildegard Lobinger; Srividya Ramakrishnan; Prashant P. Deshpande; Jeffrey T. Bien; Chiajen Lai; Chenchi Wang; Peter Riebel; John Anthony Grosso

Archive | 2007

Solvatos cristalinos de derivados de (1S)-1,5-anhidro-1-C-(3-((fenil)metil)fenil)-D-glucitol con alcoholes como inhibidores de SGLT2 para el tratamiento de diabetes

Jack Z. Gougoutas; Hildegard Lobinger; Srividya Ramakrishnan; Prashant P. Deshpande; Jeffrey T. Bien; Chiajen Lai; Chenchi Wang; Peter Riebel; John Anthony Grosso; Alexandra A. Nirschl; Janak Singh; John D. Dimarco

Archive | 2007

Solvates cristallins et complexes de dérivés de (is)-1,5-anhydro-l-c-(3-((phényl)méthyl)phényl)-d-glucitol avec des acides aminés en tant qu'inhibiteurs de sglt2 pour le traitement du diabète

Jack Z. Gougoutas; Hildegard Lobinger; Srividya Ramakrishnan; Prashant P. Deshpande; Jeffrey T. Bien; Chiajen Lai; Chenchi Wang; Peter Riebel; John Anthony Grosso; Alexandra A. Nirschl; Janak Singh; John D. Dimarco

Explore More

Collaboration

Dive into the Jeffrey T. Bien's collaboration.

Top Co-Authors
Avatar

Chiajen Lai

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

John Anthony Grosso

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Prashant P. Deshpande

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Alexandra A. Nirschl

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Jack Z. Gougoutas

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Janak Singh

Loyola University New Orleans

View shared research outputs
Top Co-Authors
Avatar

John D. Dimarco

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Srividya Ramakrishnan

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Yeung Y. Chan

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors
Avatar

Ambarish K. Singh

Bristol-Myers Squibb

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge